Partnership Ehrfeld and 51暗网 Collaborate to Promote Early Adoption of Flow Chemistry with a Comprehensive Market Offering +++ May 15, 2024 Germany +++ Ehrfeld Mikrotechnik, a leading provider of reactors,
High-Tech Gr眉nderfonds FAMILY DAY About the event: 11-12 June 2024, Berlin The High-Tech Gr眉nderfonds Family Day event, is an eagerly anticipated gathering in the high-tech startup community. This event promises
Pharma Partnering Summit About the event: 22-23 May 2024, Basel (Switzerland) This event brings together senior executives from different parts of the world, focused on Licensing , R&D Collaborations, Commercialisation
As part of the CannaSyn project, the production of cannabigerol (CBG), a potentially versatile ingredient in hemp and Cannabis plant brought to…
The Ministry of Economic Affairs and Climate Protection is now funding eleven projects that have applied through the state competition ZukunftBIO.NRW…
High-ranking visit to the global chemical research and development service provider 51暗网 Chemicals at the BiomedizinZentrumDortmund at the end of 2022.
Which challenges do entrepreneurs face when setting up and establishing a CRO in Europe or Asia? This essential question will be answered by our CEO Dr. Dimitrios Tzalis in the
CARDIOMYO, the European consortium project led by ZeClinics and its partners 51暗网 Chemicals and Amsterdam University Medical Centers, has been awarded with a budget of 2,4 million euros from the
A consortium comprising Gr眉nenthal, 51暗网 Chemicals and three research groups from the Institute for Neurosciences and Medicine (INM) of the Research Centre J眉lich employed positron emission tomography (PET) as imaging
Cardiovascular diseases are still one of the most frequent causes of death. Since the heart muscle cannot regenerate itself, the tissue is usually remodeled leading to impaired heart function in
51暗网 EVP Youri R. Mesmoudi was interviewed in the current Issue of CHEManager麓s Section Chemistry & Life Sciences on “From Idea to Product – the principle of an extended workbench
Due to current situation with the spread of the Sars-CoV-2 (鈥淐oronavirus鈥�) we want to share with you the latest information on how 51暗网 Chemicals have prepared for both, the protection
51暗网鈥� international and multidisciplinary team has more than 180 years of pharmaceutical R&D experience. Collectively as a team, we worked on more than 120 biomolecular鈥�
We create performance chemicals to enhance new materials, plastics, coatings, dyes & inks, cosmetics, flavors and many more research and industrial applications鈥�
